framycetin has been researched along with bekanamycin in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 8 (40.00) | 29.6817 |
| 2010's | 8 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alborn, WE; Allen, NE; Kirst, HA; Toth, JE | 1 |
| Cedergren, R; Leclerc, F | 1 |
| Cashman, DJ; Kellogg, GE; Rife, JP | 1 |
| Baboolal, N; Tok, JB; Wong, W | 1 |
| Hines, JV; Means, JA | 1 |
| Aboul-ela, F; Allam, K; Bodoor, K; Boisdore, M; Boyapati, V; Gopu, V; Miller, J; Treleaven, WD; Weldeghiorghis, T | 1 |
| Altman, RB; Blanchard, SC; Feldman, MB; Terry, DS | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Herdewijn, P; Maiti, M; Nauwelaerts, K | 1 |
| Chang, CW; Takemoto, JY | 1 |
| Di Giorgio, A; Duca, M; Tran, TP; Vo, DD | 1 |
| Cho, J; Hamasaki, K; Killian, J; Rando, RR | 1 |
| Brännvall, M; Kirsebom, LA; Mikkelsen, NE; Virtanen, A | 1 |
| Rando, RR; Ryu, DH | 1 |
| Barbieri, CM; Kaul, M; Pilch, DS; Srinivasan, AR | 1 |
| Belousoff, MJ; Graham, B; Spiccia, L; Tor, Y | 1 |
| Cowan, JA; Patwardhan, A | 1 |
| Chen, Y; Fierke, CA; Liu, X | 1 |
| Fridman, M; Herzog, IM; Louzoun Zada, S | 1 |
| Borovika, A; Khomutnyk, Y; Lee, J; Nagorny, P | 1 |
20 other study(ies) available for framycetin and bekanamycin
| Article | Year |
|---|---|
Comparison of aminoglycoside antibiotics with respect to uptake and lethal activity in Escherichia coli.
Topics: Aminoglycosides; Anti-Bacterial Agents; Biological Transport; Escherichia coli; Indicators and Reagents; Kinetics; Structure-Activity Relationship | 1987 |
Modeling RNA-ligand interactions: the Rev-binding element RNA-aminoglycoside complex.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antiviral Agents; Binding Sites; Computer Simulation; Crystallography, X-Ray; Gene Products, rev; Humans; Ligands; Macromolecular Substances; Models, Chemical; Models, Molecular; Nucleic Acid Conformation; Protein Conformation; Rhinovirus; RNA, Viral; Structure-Activity Relationship | 1998 |
Which aminoglycoside ring is most important for binding? A hydropathic analysis of gentamicin, paromomycin, and analogues.
Topics: Algorithms; Aminoglycosides; Anti-Bacterial Agents; Binding Sites; Carbohydrate Conformation; Carbohydrate Sequence; Escherichia coli; Gentamicins; Models, Molecular; Molecular Sequence Data; Nuclear Magnetic Resonance, Biomolecular; Paromomycin; RNA, Ribosomal, 16S; Structure-Activity Relationship; Thermodynamics | 2001 |
Binding of aminoglycoside antibiotics with modified A-site 16S rRNA construct containing non-nucleotide linkers.
Topics: Aminoglycosides; Anisotropy; Anti-Bacterial Agents; Base Pairing; Binding Sites; Cyclization; Drug Design; Indicators and Reagents; Kinetics; Nucleic Acid Conformation; RNA, Complementary; RNA, Ribosomal, 16S; Structure-Activity Relationship | 2002 |
Fluorescence resonance energy transfer studies of aminoglycoside binding to a T box antiterminator RNA.
Topics: Aminoglycosides; Bacterial Proteins; Fluorescence Resonance Energy Transfer; RNA-Binding Proteins; RNA, Bacterial; T-Box Domain Proteins | 2005 |
Design and implementation of an ribonucleic acid (RNA) directed fragment library.
Topics: Binding Sites; Chemistry, Physical; Databases, Factual; Drug Design; Ligands; Magnetic Resonance Spectroscopy; Molecular Weight; Organic Chemicals; Quality Control; RNA; Small Molecule Libraries | 2009 |
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
Topics: Aminoglycosides; Binding Sites; Conserved Sequence; Cryoelectron Microscopy; Fluorescence Resonance Energy Transfer; Kanamycin; Kinetics; Models, Molecular; Mutation; Neomycin; Oligonucleotides; Protein Binding; Protein Transport; Reproducibility of Results; Ribosomes; RNA; RNA, Transfer | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Pre-microRNA binding aminoglycosides and antitumor drugs as inhibitors of Dicer catalyzed microRNA processing.
Topics: Aminoglycosides; Antineoplastic Agents; Base Sequence; DEAD-box RNA Helicases; Humans; MicroRNAs; Models, Biological; Molecular Sequence Data; Ribonuclease III; RNA Processing, Post-Transcriptional | 2012 |
Antifungal Amphiphilic Aminoglycosides.
Topics: | 2014 |
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; DEAD-box RNA Helicases; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Models, Molecular; Molecular Sequence Data; Neoplasms; Ribonuclease III; Ribosomes; Tetracyclines | 2015 |
Minimal RNA constructs that specifically bind aminoglycoside antibiotics with high affinities.
Topics: Aminoglycosides; Anti-Bacterial Agents; Binding Sites; Gentamicins; Kanamycin; Neomycin; Nucleic Acid Conformation; RNA; Structure-Activity Relationship; Tobramycin | 1998 |
Inhibition of RNase P RNA cleavage by aminoglycosides.
Topics: Anti-Bacterial Agents; Base Sequence; Binding, Competitive; Endoribonucleases; Escherichia coli; Escherichia coli Proteins; Framycetin; Kanamycin; Kinetics; Lead; Magnesium; Models, Molecular; Molecular Sequence Data; Mycoplasma; Nucleic Acid Conformation; Paromomycin; Recombinant Proteins; Ribonuclease P; RNA; RNA, Catalytic; RNA, Ribosomal, 16S; Substrate Specificity; Transcription, Genetic | 1999 |
Aminoglycoside binding to human and bacterial A-Site rRNA decoding region constructs.
Topics: Algorithms; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Fluorescence Polarization; Framycetin; Humans; Kanamycin; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Molecular Structure; Paromomycin; Rhodamines; RNA, Ribosomal; RNA, Ribosomal, 16S; RNA, Ribosomal, 18S; Structure-Activity Relationship; Tobramycin | 2001 |
Molecular determinants of antibiotic recognition and resistance by aminoglycoside phosphotransferase (3')-IIIa: a calorimetric and mutational analysis.
Topics: Amino Acids; Anti-Bacterial Agents; Calorimetry; Catalysis; Circular Dichroism; Coenzymes; DNA Mutational Analysis; Drug Resistance, Bacterial; Escherichia coli; Hydrogen-Ion Concentration; Kanamycin; Kanamycin Kinase; Kanamycin Resistance; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mutation; Neomycin; Protein Binding; Protons; Structure-Activity Relationship; Temperature; Thermodynamics; Titrimetry | 2007 |
Cleavage of RNA oligonucleotides by aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Esterification; Framycetin; HIV Long Terminal Repeat; HIV-1; Hydrogen-Ion Concentration; Kanamycin; Kinetics; Models, Chemical; Molecular Sequence Data; Oligonucleotides; Ribosomes; RNA | 2009 |
Influence of charge and structure on the coordination chemistry of copper aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Binding Sites; Copper; Framycetin; Kanamycin; Magnetic Resonance Spectroscopy; Molecular Structure; Paromomycin; Spectrophotometry, Ultraviolet; Static Electricity; Tobramycin | 2011 |
A real-time fluorescence polarization activity assay to screen for inhibitors of bacterial ribonuclease P.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Enzyme Inhibitors; Fluorescence Polarization; Framycetin; High-Throughput Screening Assays; Kanamycin; Ribonuclease P; RNA Cleavage; RNA, Transfer | 2014 |
Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
Topics: Aminoglycosides; Anti-Bacterial Agents; Escherichia coli Proteins; Framycetin; Gram-Negative Bacteria; Kanamycin; Microbial Sensitivity Tests; Ribose; Structure-Activity Relationship; Trisaccharides | 2016 |
Chiral phosphoric acid-catalyzed desymmetrizative glycosylation of 2-deoxystreptamine and its application to aminoglycoside synthesis.
Topics: Aminoglycosides; Catalysis; Framycetin; Glycosylation; Hexosamines; Kanamycin; Phosphoric Acids; Stereoisomerism | 2017 |